Literature DB >> 30488944

Association Between Functional Impairment and Medication Burden in Adults with Heart Failure.

Parag Goyal1,2, Joanna Bryan2, Jerard Kneifati-Hayek2, Madeline R Sterling2, Samprit Banerjee3, Mathew S Maurer4, Mark S Lachs5, Monika M Safford2.   

Abstract

OBJECTIVES: To determine whether the number of medications taken by adults with heart failure (HF) and impairment in activities of daily living (ADL)-a subpopulation in whom the risks of a high medication burden may outweigh the benefits-differs from the number taken by those without impairment in ADLs.
DESIGN: Cross-sectional.
SETTING: National Health and Nutrition Examination Survey (NHANES; 2003-2014), a cross-sectional survey that produces national estimates of adults in the United States. PARTICIPANTS: Adults aged 50 and older (mean 70) with self-reported HF (N= 947; representing 4.6 million adults with HF in the United States. MEASURMENTS: We assessed ADL impairment and medication count based on self-report. ADL impairment was defined as having difficulty with or being unable to dress, feed oneself, or get in and out of bed. To determine the independent association between ADL impairment and medication count, we performed sequential Poisson multivariable regression analyses. All analyses were cross-sectional in nature and accounted for the complex survey design of NHANES.
RESULTS: Mean medication count was 7.2, and 74% of participants were taking 5 or more medications (polypharmacy). In a multivariable model, ADL impairment was not independently associated with medication count. These findings were similar for those with 3 or more hospitalizations in the prior year, declining health status, and cognitive impairment.
CONCLUSION: After adjusting for confounders including comorbidity, we found that adults with HF and ADL impairment take as many medications as those without ADL impairment. This suggests that providers may not sufficiently consider functional impairment when prescribing medications to adults with HF and thus may unnecessarily expose individuals to risk of adverse outcomes. J Am Geriatr Soc 67:284-291, 2019.
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society.

Entities:  

Keywords:  functional impairment; heart failure; polypharmacy

Year:  2018        PMID: 30488944      PMCID: PMC6790071          DOI: 10.1111/jgs.15654

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  43 in total

1.  Predictors of self-report of heart failure in a population-based survey of older adults.

Authors:  Tanya R Gure; Ryan J McCammon; Christine T Cigolle; Todd M Koelling; Caroline S Blaum; Kenneth M Langa
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-05

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

Review 3.  Pharmacotherapy of heart failure in the elderly: adverse events.

Authors:  Michael W Rich
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  The persistent exclusion of older patients from ongoing clinical trials regarding heart failure.

Authors:  Antonio Cherubini; Joaquim Oristrell; Xavier Pla; Carmelinda Ruggiero; Roberta Ferretti; Germán Diestre; A Mark Clarfield; Peter Crome; Cees Hertogh; Vita Lesauskaite; Gabriel-Ioan Prada; Katarzyna Szczerbinska; Eva Topinkova; Judith Sinclair-Cohen; David Edbrooke; Gary H Mills
Journal:  Arch Intern Med       Date:  2011-03-28

5.  US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014.

Authors:  Nadine Shehab; Maribeth C Lovegrove; Andrew I Geller; Kathleen O Rose; Nina J Weidle; Daniel S Budnitz
Journal:  JAMA       Date:  2016-11-22       Impact factor: 56.272

6.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

7.  Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans.

Authors:  Zachary A Marcum; Megan E Amuan; Joseph T Hanlon; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Mary Jo V Pugh
Journal:  J Am Geriatr Soc       Date:  2011-12-08       Impact factor: 5.562

8.  Frailty in NHANES: Comparing the frailty index and phenotype.

Authors:  Joanna Blodgett; Olga Theou; Susan Kirkland; Pantelis Andreou; Kenneth Rockwood
Journal:  Arch Gerontol Geriatr       Date:  2015-02-03       Impact factor: 3.250

9.  Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Authors:  Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

10.  Intraindividual change in SF-36 in ambulatory clinic primary care patients predicted mortality and hospitalizations.

Authors:  Vincent S Fan; David H Au; Mary B McDonell; Stephan D Fihn
Journal:  J Clin Epidemiol       Date:  2004-03       Impact factor: 6.437

View more
  13 in total

Review 1.  Deprescribing in Older Adults With Cardiovascular Disease.

Authors:  Ashok Krishnaswami; Michael A Steinman; Parag Goyal; Andrew R Zullo; Timothy S Anderson; Kim K Birtcher; Sarah J Goodlin; Mathew S Maurer; Karen P Alexander; Michael W Rich; Jennifer Tjia
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

2.  Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study).

Authors:  Matthew T Mefford; Alysse Sephel; Melissa K Van Dyke; Ligong Chen; Raegan W Durant; Todd M Brown; Matthew Fifolt; Juan Maya; Parag Goyal; Monika M Safford; Emily B Levitan
Journal:  Am J Cardiol       Date:  2019-02-23       Impact factor: 2.778

3.  Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study.

Authors:  Madeline R Sterling; Joanna Bryan Ringel; Laura C Pinheiro; Monika M Safford; Emily B Levitan; Erica Phillips; Todd M Brown; Oanh K Nguyen; Parag Goyal
Journal:  Circ Heart Fail       Date:  2021-12-06       Impact factor: 8.790

Review 4.  Cardiac Rehabilitation to Optimize Medication Regimens in Heart Failure.

Authors:  Parag Goyal; Eiran Z Gorodeski; Zachary A Marcum; Daniel E Forman
Journal:  Clin Geriatr Med       Date:  2019-06-21       Impact factor: 3.076

5.  Complex and Potentially Harmful Medication Patterns in Heart Failure with Preserved Ejection Fraction.

Authors:  Lina M Brinker; Matthew C Konerman; Pedram Navid; Michael P Dorsch; Jennifer McNamara; Cristen J Willer; Mary E Tinetti; Scott L Hummel; Parag Goyal
Journal:  Am J Med       Date:  2020-08-18       Impact factor: 4.965

Review 6.  Dependence and reduced motor function in heart failure: future directions for well-being.

Authors:  Hidetaka Hibino; Stacey L Gorniak
Journal:  Heart Fail Rev       Date:  2021-07-24       Impact factor: 4.654

7.  Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).

Authors:  Peter J Kennel; Jerard Kneifati-Hayek; Joanna Bryan; Samprit Banerjee; Irina Sobol; Mark S Lachs; Monika M Safford; Parag Goyal
Journal:  BMC Cardiovasc Disord       Date:  2019-04-01       Impact factor: 2.298

8.  Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial.

Authors:  Yuzhong Wu; Wengen Zhu; Xin He; Ruicong Xue; Weihao Liang; Fangfei Wei; Zexuan Wu; Yuanyuan Zhou; Dexi Wu; Jiangui He; Yugang Dong; Chen Liu
Journal:  Br J Gen Pract       Date:  2020-12-28       Impact factor: 5.386

Review 9.  Polypharmacy definition and prevalence in heart failure: a systematic review.

Authors:  Janine Beezer; Manal Al Hatrushi; Andy Husband; Amanj Kurdi; Paul Forsyth
Journal:  Heart Fail Rev       Date:  2021-07-02       Impact factor: 4.654

10.  The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fraction.

Authors:  Lauren Gilstrap; Andrea M Austin; Barbara Gladders; Parag Goyal; A James O'Malley; Amber Barnato; Anna N A Tosteson; Jonathan S Skinner
Journal:  J Am Geriatr Soc       Date:  2021-06-15       Impact factor: 7.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.